Elsevier

IJC Heart & Vasculature Template

Write in a clean editor, then format for IJC Heart & Vasculature in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

About the IJC Heart & Vasculature format

IJC Heart & Vasculature is a peer-reviewed journal published by Elsevier, covering Atrial Fibrillation Management and Outcomes, Cardiovascular Function and Risk Factors, Cardiac Imaging and Diagnostics.

PublisherElsevier
Reference styleNumbered (Elsevier)
Numbered — [1], [2] in the text
[1] A. Smith, B. Jones, C. Lee, A representative article title, IJC Heart & Vasculature 12 (2023) 45–58.

Formats any DOI in IJC Heart & Vasculature style. No sign-up.

Publishes research inAtrial Fibrillation Management and Outcomes Cardiovascular Function and Risk Factors Cardiac Imaging and Diagnostics Cardiac Valve Diseases and Treatments Acute Myocardial Infarction Research
ISSN2352-9067
Citation impact (2-yr)1.8
h-index47
i10-index518
Total citations16,983
Article processing charge$2,696
Open accessYes
Top institutions publishing hereWest German Heart and Vascular Center Essen
Journal websitewww.journals.elsevier.com
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in IJC Heart & Vasculature per year

30
2014
103
2015
53
2016
83
2017
85
2018
145
2019
254
2020
229
2021
221
2022
160
2023
250
2024
252
2025

Citation impact of IJC Heart & Vasculature by publication year

322
2014
1.7K
2015
1.2K
2016
407
2017
1.3K
2018
2.2K
2019
3.3K
2020
2.5K
2021
1.9K
2022
1K
2023
826
2024
234
2025

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in IJC Heart & Vasculature

Doxorubicin induced heart failure: Phenotype and molecular mechanisms

Maria Mitry, John G. Edwards · 25 Nov 2015

Long term survival of childhood cancers is now more than 70%. Anthracyclines, including doxorubicin, are some of the most efficacious anticancer drugs available. However, its use as a chemotherapeutic agent is severely hindered by its dose-limiting toxicities. Most notably observed is cardiotoxicity, but other organ systems are also degraded by doxorubicin use. Despite the years…

Assessment of pulmonary artery pressure by echocardiography—A comprehensive review

Sathish Parasuraman, Seamus Walker, Brodie Loudon et al. · 5 Jul 2016

Pulmonary hypertension is a pathological haemodynamic condition defined as an increase in mean pulmonary arterial pressure ≥ 25 mmHg at rest, assessed using gold standard investigation by right heart catheterisation. Pulmonary hypertension could be a complication of cardiac or pulmonary disease, or a primary disorder of small pulmonary arteries. Elevated pulmonary pressure (PAP) is associated…

COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications

Monika Gawałko, Agnieszka Kapłon‐Cieślicka, Mathias Hohl et al. · 1 Sep 2020

Coronavirus disease 2019 (COVID-19) is a novel, highly transmittable and severe strain disease, which has rapidly spread worldwide. Despite epidemiological evidence linking COVID-19 with cardiovascular diseases, little is known about whether and how COVID-19 influences atrial fibrillation (AF), the most prevalent arrhythmia in clinical practice. Here, we review the available evidence for prevalence and incidence…

The circular RNA MICRA for risk stratification after myocardial infarction

Antonio Salgado‐Somoza, Lu Zhang, Mélanie Vausort et al. · 10 Nov 2017

BACKGROUND: A significant proportion of patients develop heart failure (HF) after acute myocardial infarction (MI). Predicting this development with novel biomarkers would allow tailoring healthcare to each individual. We recently identified a circular RNA called MICRA which was associated with HF development after MI. Here, we tested whether MICRA was able to risk stratify MI…

Cardiovascular disease and brain health: Focus on white matter hyperintensities

Francesco Moroni, Enrico Ammirati, Maria A. Rocca et al. · 14 May 2018

Diseases affecting the brain contribute to a substantial proportion of morbidity and mortality in the general population. Conditions such as stroke, dementia and cognitive impairment have a prominent impact on global public health. Despite the heterogeneous clinical manifestations of these conditions and their diverse prognostic implications, current evidence supports a role for cardiovascular disease as…

IJC Heart & Vasculature template — frequently asked questions

How do I write a paper in the IJC Heart & Vasculature format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the IJC Heart & Vasculature template. When you export, DocuGuru compiles the paper into the official Elsevier format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does IJC Heart & Vasculature use?
IJC Heart & Vasculature uses Numbered (Elsevier) references, shown as numbered [1], [2] markers in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: [1] A. Smith, B. Jones, C. Lee, A representative article title, IJC Heart & Vasculature 12 (2023) 45–58.
Do I need to know LaTeX to submit to IJC Heart & Vasculature?
No. DocuGuru generates the elsarticle LaTeX class and compiles the PDF for you in the background, so you get a Elsevier-ready IJC Heart & Vasculature document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the IJC Heart & Vasculature template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the IJC Heart & Vasculature format with correct headings, figures, tables, and numbered citations.
Who publishes IJC Heart & Vasculature?
IJC Heart & Vasculature is a multidisciplinary journal published by Elsevier. DocuGuru's IJC Heart & Vasculature template matches Elsevier's official submission format.
Can I export a submission-ready IJC Heart & Vasculature PDF?
Yes — DocuGuru produces a PDF built with the official IJC Heart & Vasculature template (the elsarticle class) that is ready to submit to Elsevier, together with the matching LaTeX source files.
How much does the IJC Heart & Vasculature template cost?
You can start writing in the IJC Heart & Vasculature template for free. Exporting the final submission-ready IJC Heart & Vasculature PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the IJC Heart & Vasculature template